Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Pillararene‐Based Stimuli‐Responsive Supramolecular Delivery Systems for Cancer Therapy
2024 Standout
The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
2023 Standout
2 intermediate papers

Works of Donna Griebel being referenced

FDA Drug Approval Summaries: Oxaliplatin
2004
Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
2002

Author Peers

Author Last Decade Papers Cites
Donna Griebel 144 203 68 171 146 20 669
Guillermo Rossiter 390 125 32 216 206 23 850
Sei-Jong Kim 256 166 60 105 139 22 620
Kurt Neumann 103 73 44 139 161 28 793
Virginia Davenport 146 52 59 138 135 21 624
Jung Wook Park 144 83 37 239 219 22 584
Ben van den Borne 76 145 36 338 216 27 675
Shih-Chen Chang 205 194 15 137 177 17 669
J.M. Gornet 278 134 16 177 351 24 777
S Kaufman 122 95 23 55 49 30 675
W. C. J. Hop 331 47 43 274 136 28 821

All Works

Loading papers...

Rankless by CCL
2026